IDEAYA Biosciences P/CF Ratio 2011-2026 | IDYA

Annual P/CF Ratio IDEAYA Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-38.3	-6.87	-21.8	-8.56	-10.5	7.84	-2.64	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.84	-38.3	-11.5

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.654	-	2.43 %	$ 254 M	Germany
Altimmune ALT	-4.71	$ 3.47	3.89 %	$ 306 M	USA
I-Mab IMAB	-0.266	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	11.6	-	-	$ 40.3 B	USA
Genfit SA GNFT	1.68 K	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-23.1	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-17.6	$ 219.83	-0.92 %	$ 5 B	Danmark
Midatech Pharma plc MTP	-13.2	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.88	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	-0.64	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	-8.36	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-4.82	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.0018	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-1.2	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-5	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-1.71	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-2.73	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	-89	-	-	-	Russia
Grifols, S.A. GRFS	14.1	$ 7.69	1.39 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	-0.0603	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-0.826	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-0.401	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-0.0633	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	-2	$ 0.6	-2.83 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	-0.224	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	-5.11	$ 13.01	2.12 %	$ 784 M	USA
Atreca BCEL	-0.607	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	7.5	-	-4.8 %	$ 255 M	USA
Heron Therapeutics HRTX	-7.19	$ 0.8	2.29 %	$ 133 M	USA
BeiGene, Ltd. BGNE	-1.8 K	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-14.5	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-0.588	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.024	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	-4.42	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	13.8	$ 91.13	0.38 %	$ 17.8 B	USA
Checkpoint Therapeutics CKPT	-5.15	-	-	$ 169 M	USA
Clovis Oncology CLVS	-1.18	-	-7.23 %	$ 13 M	USA
Inovio Pharmaceuticals INO	-1.77	$ 1.6	0.95 %	$ 35.5 M	USA
Aeglea BioTherapeutics AGLE	-4.6	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-4.82	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	-8.74	$ 21.15	4.86 %	$ 3.48 B	USA
Akero Therapeutics AKRO	-14.1	-	-	$ 3.67 B	USA
Inventiva S.A. IVA	-11.2	$ 6.07	5.02 %	$ 138 M	France
Arbutus Biopharma Corporation ABUS	-5.18	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	-2.7	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-1.3	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	-0.698	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	-1.79	-	-	$ 123 M	USA
Deciphera Pharmaceuticals DCPH	-8.18	-	-	$ 2.18 B	USA
Cardiff Oncology CRDF	-3.07	$ 1.8	0.08 %	$ 120 M	USA